Home » Topics » BioWorld Science

BioWorld Science
RSS

New 5-FU formulation reduces toxicity in mice

Nov. 28, 1996

Canadian scientists identify new target for respiratory drugs

Nov. 28, 1996

Intracardiac illuminator offered for licensing

Nov. 28, 1996

Novel vaccine delivery system available for licensing

Nov. 28, 1996

Licenses available for lung function monitor

Nov. 28, 1996

Exclusive worldwide rights offered for peptide-cleaving endopeptidase

Nov. 28, 1996

Cancer diagnostic based on p53 offered for licensing

Nov. 28, 1996

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Diagnostic kits for beta-thalassemia available for licensing

Nov. 28, 1996

Purified or recombinant TAP 29 with anti-HIV activity available for licensing

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...